HealthEquity, Inc. (NASDAQ:HQY) Shares Bought by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. lifted its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 2.1% during the fourth quarter, HoldingsChannel reports. The fund owned 70,592 shares of the company’s stock after acquiring an additional 1,453 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in HealthEquity were worth $6,773,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the company. Private Advisor Group LLC purchased a new position in shares of HealthEquity during the 3rd quarter worth approximately $208,000. Wealth Enhancement Advisory Services LLC raised its stake in shares of HealthEquity by 18.8% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 3,649 shares of the company’s stock worth $299,000 after buying an additional 578 shares in the last quarter. State of Alaska Department of Revenue raised its stake in shares of HealthEquity by 7.2% during the 3rd quarter. State of Alaska Department of Revenue now owns 10,146 shares of the company’s stock worth $830,000 after buying an additional 685 shares in the last quarter. Nisa Investment Advisors LLC raised its stake in shares of HealthEquity by 19.8% during the 3rd quarter. Nisa Investment Advisors LLC now owns 3,420 shares of the company’s stock worth $280,000 after buying an additional 566 shares in the last quarter. Finally, New York State Teachers Retirement System raised its stake in shares of HealthEquity by 1.4% during the 3rd quarter. New York State Teachers Retirement System now owns 83,997 shares of the company’s stock worth $6,875,000 after buying an additional 1,146 shares in the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares in the company, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the sale, the director now owns 19,061 shares of the company’s stock, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 39,000 shares of company stock valued at $3,895,788. Company insiders own 2.20% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on HQY shares. Wells Fargo & Company upped their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research note on Wednesday. JMP Securities upped their price target on shares of HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research note on Tuesday, December 10th. Royal Bank of Canada boosted their price target on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. Barrington Research boosted their price target on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Monday, December 2nd. Finally, Mizuho started coverage on HealthEquity in a research note on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target on the stock. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, HealthEquity has a consensus rating of “Moderate Buy” and an average price target of $113.54.

HealthEquity Stock Up 2.6 %

HQY opened at $109.76 on Friday. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm has a market cap of $9.51 billion, a P/E ratio of 100.70, a PEG ratio of 1.60 and a beta of 0.55. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $115.59. The business’s fifty day simple moving average is $104.84 and its 200 day simple moving average is $93.08.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period last year, the business posted $0.40 EPS. As a group, equities research analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.